These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
806 related items for PubMed ID: 8587840
1. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours. Bodrogi I, Baki M, Horti J, Géczi L, Liszka G, Ottó S, Hindy I, Eckhardt S, Sugár J. Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840 [Abstract] [Full Text] [Related]
3. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M. Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [Abstract] [Full Text] [Related]
4. [Management of advanced seminoma: retrospective study of 96 patients]. Bompas E, Fléchon A, Biron P, Droz JP. Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279 [Abstract] [Full Text] [Related]
5. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. N Engl J Med; 2007 Jul 26; 357(4):340-8. PubMed ID: 17652649 [Abstract] [Full Text] [Related]
7. [A case of complete remission obtained with etoposide cis-platinum combination chemotherapy in advanced testicular cancer]. Iinuma S, Yamamoto H, Hagiwara M, Nakazono M. Gan To Kagaku Ryoho; 1990 Feb 26; 17(2):293-6. PubMed ID: 1689134 [Abstract] [Full Text] [Related]
11. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882. Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882. J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336 [Abstract] [Full Text] [Related]
13. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin. Brada M, Horwich A, Peckham MJ. Cancer Treat Rep; 1987 Jun 01; 71(6):655-6. PubMed ID: 2438041 [Abstract] [Full Text] [Related]
15. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE. J Urol; 2008 Jan 01; 179(1):163-6. PubMed ID: 18001800 [Abstract] [Full Text] [Related]
16. [Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]. Baume D, Pico JL, Droz JP, Ostronoff M, Azab M, Gilles E, Ghosn M, Salloum E, Gouyette A, Beaujean F. Bull Cancer; 1990 Jan 01; 77(2):169-80. PubMed ID: 2156588 [Abstract] [Full Text] [Related]
18. Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors. Bodrogi I, Baki M, Horti J, Liszka G, Ottó S, Hindy I, Sugár J, Eckhardt S. Neoplasma; 1990 Jan 01; 37(4):445-50. PubMed ID: 1700311 [Abstract] [Full Text] [Related]
19. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients. Gholam D, Fizazi K, Terrier-Lacombe MJ, Jan P, Culine S, Theodore C. Cancer; 2003 Aug 15; 98(4):745-52. PubMed ID: 12910518 [Abstract] [Full Text] [Related]
20. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma. Newlands ES. Semin Oncol; 1985 Mar 15; 12(1 Suppl 2):37-41. PubMed ID: 2579442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]